: A platform for anticancer drug discovery and personalized therapies.

Cancer is a complex disease whereby multiple genetic aberrations, epigenetic modifications, metabolic reprogramming, and the microenvironment contribute to the development of a tumor. In the traditional anticancer drug discovery pipeline, drug candidates are usually screened using two-dimensional or three-dimensional cell culture. However, these methods fail to accurately mimic the human disease state.